Tagged Articles

diet pill 24 articles

Health authorities warn against dangerous weight loss products sold online

Singapore health authorities are warning that a dietary supplement sold through direct sales and online by Jessie Cosmetics contains dangerously high levels of banned substances that could pose a risk to consumers. Anyang Herbal Red and Anyang Herbal Blue were marketed as weight loss products and claimed to contain “100 percent natural ingredients.” Instead, the products contained the hidden drug ingredient sibutramine. Anyang Herbal Red also contained two other hidden drugs, diclofenac and phenolphthalein. Sibutramine is a stimulant that used to be sold as a weight loss product in the U.S. but was banned by the Food in Drug Administration ... Read More

The Doctors show warns viewers about dangers of ‘shady diet pills’

The Doctors TV show recently cautioned viewers about “shady diet pills.” The contents of these dietary supplements may contain harmful ingredients, and doubling or tripling doses for faster results may have deadly consequences. Lead host of The Doctors, Dr. Travis Lane Stork, presented the case of a 25-year-old U.K. father who “all he did is he overdosed accidentally when he took eight – just eight – of these diet pills, DMP,” he said. The pills caused the man’s body temperature to rise to 107 degrees. The process did burn calories, but it also caused deep burns in his leg, leading to tissue death. The ... Read More

FDA approves new diet pill Contrave

A new prescription diet pill has been given clearance by the Food and Drug Administration (FDA) for marketing in the United States. Contrave, made by Orexigen Therapeutics, is a combination of bupropion, an antidepressant that is also used for smoking cessation, and naltrexone, a drug used to treat drug and alcohol dependence. Contrave is approved for overweight or obese patients with a body mass index (BMI) of 30 or higher, as well as people with a BMI of 27 or higher with at least one other health issue such as diabetes. Patients treated with Contrave lost an average of 4.2 ... Read More

FDA panel recommends approving diabetes treatment for obese patients

A Food and Drug Administration (FDA) advisory panel has given a thumbs-up recommendation to Novo Nordisk’s type 2 diabetes drug liraglutide for the treatment of chronic obesity in patients with at least one weight-related health issue, such as hypertension or pre-diabetes. Liraglutide, known commercially as Victoza, would be sold under the label Saxenda for the obesity indication if it is approved by the FDA. The agency is not required to follow the recommendations of its advisory panels, but it usually does. The positive recommendation was based on a clinical trial in which patients were given 3 mg of liraglutide. About ... Read More

RegenESlim appetite control capsules recalled due presence of dangerous ingredient

Certain lots of RegenESlim appetite control dietary supplements are being recalled because they contain an ingredient that may cause deadly side effects. A Food and Drug Administration (FDA) analysis found in two lots of RegenESlim the presence of DMAA, also known as 1,3-dimethylamylamine, methylhexanamine, or geranium extract, commonly used as a stimulant, pre-workout, and weight loss ingredient in supplements. The agency has warned that DMAA is potentially dangerous to health as it can narrow blood vessels and arteries, which can cause a rise in blood pressure or other cardiovascular problems such as shortness of breath, arrhythmias, tightening in the chest, ... Read More

Drug company tests high doses of type 2 diabetes drug Victoza as possible weight loss treatment

A high-dose version of the type 2 diabetes drug Victoza is being tested as a new diet drug, and studies show it can melt up to 10 percent of body mass. Victoza is currently available in 1.2 mg and 1.8 mg doses to help drive down blood sugar levels in type 2 diabetics. Pre-market studies on the drug already identified weight loss as a side effect of the medication. Thus, the drug’s maker, Novo Nordisk, decided to see if higher doses of Victoza could lead to greater weight loss in obese people without the disease. Novo Nordisk began testing the ... Read More

FDA delays decision on diet pill based on heart risk evaluation

The Food and Drug Administration (FDA) has delayed its decision by three months on the new diet pill contrave in order to reach an agreement with drug company Orexigen Therapeutics regarding post-marketing obligations related to the evaluation of cardiovascular risks associated with the drug. Orexigen and the FDA are currently in talks about the package insert and other post-marketing requirements. The FDA had rejected the drug in 2011, saying it needed more studies to put to rest concerns about heart risks. Orexigen came back nearly three years later with an analysis involving 8,900 patients showing patients taking contrave did not ... Read More

Type 2 diabetes drug Victoza tested as potential diet drug

The type 2 diabetes drug Victoza (liraglutide) can help overweight and obese people without diabetes lose weight, according to a new multinational clinical trial, but the drug comes with some risks. Victoza, an injectable drug in a class of diabetes medications known as glucagonlike peptide-1 (GLP-1) agonist, was approved by the Food and Drug Administration (FDA) in January 2010 to help lower blood sugar levels in people with type 2 diabetes. In an effort to expand the indication to non-diabetics who are overweight, the medication was pitted against a placebo and the currently marketed anti-obesity drug Qsymia, a combination of ... Read More

Drug company Orexigen conducts tests on experimental diet pill Contrave

Interim analysis of Orexigen Therapeutics’ experimental weight loss drug Contrave showed successful results, setting the stage for possible marketing approval by United States drug regulators by June 2014. The Food and Drug Administration (FDA) rejected Orexigen’s bid for approval in February 2011, saying it needed more data from a large-scale study on the long-term effects the obesity medication has on the heart. Contrave is a combination of two already approved medications – bupropion, which is the active ingredient in the antidepressant Wellbutrin, and the anti-addiction drug naltrexone. Contrave is designed to influence the hypothalamus in in order to decrease food ... Read More

Workout powder, diet pill found to contain meth-like drug

Two supplements – one a popular pre-workout powder and the other a weight-loss pill – contain an undeclared ingredient similar to the street drug meth, that federal officials say poses possible health hazards. The sports supplement, sold under the brand name Craze and made by Driven Sports, is marketed as a natural supplement that provides “unrelenting energy and focus” during workouts. It is sold at retailers such as Wal-Mart and GNC. The supplement was named “New Supplement of the Year” in a 2012 Bodybuilding.com survey. The diet pill, called Detonate, is distributed by Gaspari Nutrition and sold at a variety of ... Read More